Cytokine-chemokine profiles in the hippocampus of patients with mesial temporal lobe epilepsy and hippocampal sclerosis
- 10 January 2022
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 180, 106858
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Sanidad, Consumo y Bienestar Social (65269705)
- Ministry of Health of the Czech Republic (NU21-04-00305)
- Agentura Pro Zdravotnický Výzkum České Republiky
This publication has 35 references indexed in Scilit:
- Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokinesJournal of Neuroinflammation, 2012
- Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune responseCellular and Molecular Life Sciences, 2012
- The role of inflammation in epilepsyNature Reviews Neurology, 2010
- Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharideJournal of Neuroinflammation, 2010
- Cellular injury and neuroinflammation in children with chronic intractable epilepsyJournal of Neuroinflammation, 2009
- Epileptogenesis in the immature brain: emerging mechanismsNature Reviews Neurology, 2009
- Nuclear factor‐κB regulates seizure threshold and gene transcription following convulsant stimulationJournal of Neurochemistry, 2007
- Evidence of tumor necrosis factor receptor 1 signaling in human temporal lobe epilepsyExperimental Neurology, 2006
- Modulating CCR2 and CCL2 at the blood–brain barrier: relevance for multiple sclerosis pathogenesisBrain, 2005
- Degree of hippocampal atrophy is not related to a history of febrile seizures in patients with proved hippocampal sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2000